Harmony Biosciences Holdings Cash Flow Statement (2019-2026) | HRMY

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
14.12M-9.62M19.06M21.48M23.53M87.94M-37.43M29.48M34.30M38.46M26.61M38.33M11.59M46.09M78.94M45.56M39.78M50.87M37.11M32.49M
Depreciation and Depletion (Quarter)
0.10M0.10M0.12M0.12M0.09M0.10M0.11M0.10M0.10M0.14M0.16M0.16M0.09M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
3.81M4.66M3.94M4.63M7.37M6.97M6.94M6.56M7.79M7.96M9.39M10.39M10.96M11.45M10.07M12.50M11.46M10.97M9.97M10.62M
Deferred Taxes (Quarter)
-4.26M-3.44M-4.19M-6.91M1.12M-3.48M-14.28M-4.83M-6.71M-4.31M-6.49M-3.88M7.38M-3.86M
Gains from Sales and Divestitures (Quarter)
0.03M0.03M0.03M0.03M0.01M0.01M0.14M0.14M0.12M0.17M0.22M0.22M0.18M
Gains from Investment Securities (Quarter)
1.30M5.98M1.96M0.39M0.09M1.53M11.60M0.10M0.19M6.26M-36.03M0.47M0.03M0.09M1.83M1.31M8.01M7.98M-34.10M1.04M
Non-cash Items (Quarter)
27.89M4.32M4.42M4.67M29.80M5.53M51.95M16.30M
Cash from Operations (Quarter)
18.07M30.42M37.53M28.85M33.73M55.20M26.68M42.56M37.06M63.10M76.67M31.14M42.62M70.50M75.56M33.99M79.33M108.73M126.15M27.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
4.63M4.57M4.64M5.08M5.96M5.96M5.96M0.64M5.96M5.96M-15.17M5.96M5.96M5.96M22.07M5.96M5.96M5.96M0.28M0.22M
Amortization of Deferred Charges (Quarter)
0.70M0.46M0.42M0.41M0.41M0.42M0.42M0.42M0.42M
Depreciation & Amortization (CF) (Quarter)
0.10M0.10M0.12M0.12M0.09M0.10M0.11M0.10M0.10M0.14M0.16M0.16M0.09M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
7.58M2.01M1.64M3.29M11.69M5.24M-0.33M-2.17M11.24M3.45M6.88M5.58M3.44M-1.66M1.53M22.94M-12.99M7.67M-3.86M11.44M
Change in Inventory (Quarter)
0.55M-0.15M-0.37M0.17M-0.39M-0.31M0.40M-0.21M0.76M0.23M0.28M0.49M-0.21M1.27M0.28M-0.81M-0.28M0.78M-1.52M-0.08M
Change in Account Payables (Quarter)
-2.38M2.17M-3.18M5.90M-0.24M3.39M-6.26M2.63M0.15M-0.02M6.20M-2.59M6.14M-12.15M3.21M3.71M10.84M-1.96M-8.65M10.91M
Change in Accured Expenses (Quarter)
5.81M5.94M8.72M-3.59M8.99M37.76M-22.75M-1.85M3.14M14.42M30.77M-8.23M-16.87M24.32M12.57M-5.46M-7.03M28.03M52.45M-46.18M
Other Working Capital Changes (Quarter)
-0.33M0.05M-0.16M-0.15M3.86M-3.86M7.70M-0.59M-1.64M3.99M-1.83M3.44M0.56M0.85M-1.84M2.00M3.59M-12.53M-24.84M3.00M
Investing Activities
Capital Expenditures (Quarter)
0.20M0.09M0.04M0.04M0.09M0.11M0.01M0.63M0.00M0.51M0.13M0.00M0.07M0.11M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)
8.20M45.99M17.50M32.20M22.62M18.93M25.56M24.04M30.01M21.62M19.32M19.56M20.56M27.35M
Cash from Investing Activities (Quarter)
-0.20M-0.09M-40.05M-22.45M-32.45M-46.90M-1.79M-7.77M-0.81M-36.06M-6.19M-54.86M0.74M-7.19M2.36M-19.59M-4.79M-17.63M-183.65M
Financing Activities
Other financing activities (Quarter)
8.85M
Cash from Financing Activities (Quarter)
0.65M-0.31M7.07M1.38M0.75M2.05M2.66M3.41M-0.34M-55.10M-53.52M-3.63M-3.45M-1.18M-2.74M-0.35M-2.69M-3.00M-3.02M-7.22M
Additional items
Change in Cash (Quarter)
18.52M30.02M44.60M-9.81M12.03M24.81M-17.56M44.18M28.95M7.19M-12.92M21.32M-15.69M70.07M65.63M36.00M57.05M100.95M105.50M-163.10M
Free Cash Flow (Quarter)
17.87M30.33M37.53M28.81M33.69M55.12M26.68M42.56M37.06M63.10M76.56M31.14M41.98M70.50M75.05M33.86M79.32M108.66M126.04M27.76M
Net Cash Flow (Quarter)
18.52M30.02M44.60M-9.81M12.03M24.81M-17.56M44.18M28.95M7.19M-12.92M21.32M-15.69M70.07M65.63M36.00M57.05M100.95M105.50M-163.10M